EASTLAND JULIA MARIE
Insider CIK 1500189 · DVAX Director · ONTY CFO & VP, CORP. DEVELOPMENT · LNTH Director · GRAY Director · HARP President and CEO, Director · ZNTL CEO & President, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LNTH Lantheus Holdings, Inc. | A Award | 2026-05-14 | 2026-05-18 | 4,137 | — | $0 | 8,019 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2026-02-09 | 2026-02-10 | 889 | $2.39 | $2.1K | 79,133 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2026-02-06 | 2026-02-10 | 7,866 | $2.43 | $19.1K | 80,022 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2026-01-08 | 2026-01-09 | 775,000 | — | $0 | 775,000 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award deriv | 2025-05-14 | 2025-05-16 | 4,543 | — | $0 | 4,543 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award | 2025-05-14 | 2025-05-16 | 2,537 | — | $0 | 3,882 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2025-02-03 | 2025-02-05 | 59,388 | — | $0 | 59,388 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2025-02-03 | 2025-02-05 | 59,388 | — | $0 | 87,888 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | P Buy | 2025-01-31 | 2025-02-04 | 28,500 | $1.73 | $49.3K | 28,500 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2024-12-02 | 2024-12-03 | 3,028,800 | — | $0 | 3,028,800 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award deriv | 2024-09-10 | 2024-09-12 | 2,506 | — | $0 | 2,506 | SEC↗ |
| LNTH Lantheus Holdings, Inc. | A Award | 2024-09-10 | 2024-09-12 | 1,345 | — | $0 | 1,345 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2024-05-23 | 2024-05-28 | 22,500 | — | $0 | 22,500 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2024-05-23 | 2024-05-28 | 5,357 | — | $0 | 16,071 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 40,759 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 2,765 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2024-03-11 | 2024-03-11 | 31,250 | — | $0 | 269,381 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer | 2024-03-11 | 2024-03-11 | 269,381 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2024-01-07 | 2024-01-09 | 178,500 | — | $0 | 232,003 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2023-11-26 | 2023-11-28 | 50,000 | — | $0 | 53,503 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2023-05-26 | 2023-05-31 | 22,500 | — | $0 | 22,500 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2023-05-26 | 2023-05-31 | 5,357 | — | $0 | 10,714 | SEC↗ |
| GRAY CalciMedica, Inc. | D To issuer deriv | 2023-03-23 | 2023-03-27 | 1,429 | — | $0 | 0 | SEC↗ |
| GRAY CalciMedica, Inc. | D To issuer | 2023-03-23 | 2023-03-27 | 1,429 | — | $0 | 1,429 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2023-01-24 | 2023-01-26 | 407,600 | — | $0 | 407,600 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | A Award deriv | 2022-06-02 | 2022-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | A Award deriv | 2022-06-02 | 2022-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2022-05-26 | 2022-05-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2022-05-26 | 2022-05-27 | 5,357 | — | $0 | 5,357 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2021-11-08 | 2021-11-09 | 350,000 | — | $0 | 350,000 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | A Award deriv | 2021-06-02 | 2021-06-04 | 12,500 | — | $0 | 12,500 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2021-05-28 | 2021-06-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2021-05-04 | 2021-05-07 | 10,167 | — | $0 | 10,167 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2021-05-04 | 2021-05-14 | 10,167 | — | $0 | 10,167 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | A Award deriv | 2020-09-24 | 2020-09-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2020-07-17 | 2020-07-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2020-05-28 | 2020-06-01 | 10,167 | — | $0 | 10,167 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2019-06-03 | 2019-06-05 | 10,167 | — | $0 | 10,167 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2019-02-07 | 2019-03-29 | 5,907 | — | $0 | 5,907 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 6,667 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 16,500 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 8,334 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 8,334 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 25,000 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 199,000 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 8,334 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 11,300 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 75,000 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 51,200 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 50,000 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 41,667 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 16,667 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | U Tender | 2018-03-09 | 2018-03-13 | 5,237 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2018-02-01 | 2018-02-02 | 199,000 | — | $0 | 199,000 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise deriv | 2018-01-11 | 2018-01-16 | 2,825 | — | $0 | 8,475 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise | 2018-01-11 | 2018-01-16 | 2,825 | — | $0 | 6,160 | SEC↗ |
| CASC Cascadian Therapeutics, In | F Tax w/h | 2018-01-11 | 2018-01-16 | 923 | $3.92 | $3.6K | 5,237 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-09-18 | 2017-09-20 | 16,500 | — | $0 | 16,500 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-09-18 | 2017-09-20 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-01-11 | 2017-01-13 | 11,300 | — | $0 | 11,300 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-01-11 | 2017-01-13 | 51,200 | — | $0 | 51,200 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2016-05-17 | 2016-05-19 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2015-09-24 | 2015-09-28 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2014-12-16 | 2014-12-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2013-12-12 | 2013-12-16 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2012-12-12 | 2012-12-14 | 50,000 | — | $0 | 50,000 | SEC↗ |